Back to search

The University of Edinburgh

Ass1 and its role in renal fibrosis

Abstract

dc:description.abstract

BACKGROUND: The incidence of chronic kidney disease (CKD) is rising and is the 12th most common cause of death worldwide. Currently, the only available treatments are renal replacement therapy and transplantation, both of which are significantly costly for the NHS. Therefore there is an unmet clinical need for new therapies which can tackle the manifestation of renal disease processes and progression to CKD. The pathophysiological process common to all CKDs, regardless of the initiating aetiology, is tubulointerstitial fibrosis (TIF). TIF leads to scarring of the kidney and results in loss of renal function and eventual end-stage renal disease. TIF is driven by a number of pathophysiological processes taking place in several cell types including the proximal tubule. The proximal tubule (PT) is sensitive to injury and in a damaged state has attracted attention as a driver of fibrotic disease due to de-differentiation and pro-inflammatory/ pro-fibrotic signalling. Argininosuccinate synthetase (ASS1), a ratelimiting urea cycle enzyme, is highly expressed in the PT and has been reported to be downregulated in human CKD. Furthermore, urea cycle metabolites such as citrulline have been reported to be dysregulated in renal disease. Hypothesis: Loss of tubular ASS1 expression is critical in the induction of renal fibrosis. RESULTS: Renal Ass1 expression was assessed and compared to sham operated animals in ischaemia-reperfusion injury (IRI), subtotal nephrectomy (STNx), obstructive (UUO) and reversible obstructive (rUUO) murine models. Ass1 expression was significantly downregulated in all models of injury. Ass1 loss occurred at early time points and preceded the manifestation of fibrosis. Single cell RNA-seq of the reversible UUO model was adopted to assess Ass1 expression during the progression and reversal of fibrosis. After obstruction, Ass1 was significantly depleted in fibrotic tubular epithelial cells. Upon reversal of fibrosis, Ass1 expression levels almost returned to normal. ASS1 is highly expressed in human proximal tubular epithelial cells (RPTEC/TERT1). To determine the consequences of ASS1 depletion, ASS1 was knocked-down in RPTECs. This induced upregulation of pro-fibrotic genes and downregulation of cell-cell contact genes. In RPTECs, ASS1 transcription was unaffected by pro-fibrotic, TGFβ. However, ASS1 transcription was significantly reduced in a dose-dependent manner following TNFα treatment and hypoxia. In order to further interrogate the function of Ass1 in tubular epithelial cells in vivo, Ass1 was conditionally knocked out in renal tubular cells specifically using the Pax8 CreERT2 floxed Ass1 transgenic mouse. The effect of Pax8 Cre x Ass1 flox/wt heterozygous knock-out was assessed to explore if partial loss of Ass1 exerted a haploinsufficiency effect. Heterozygous mice did not demonstrate any renal phenotype distinct from controls. A small cohort of Pax8 Cre x Ass1 flox/flox mice homozygous were assessed to interrogate the effects of full knock out of Ass1 in the kidney. Pax8Cre x Ass1 flox/flox female mice exhibited a decrease in ASS1 protein in the kidney. This under-powered study did not reveal any pathological effects in the kidney in the unchallenged state in a period of 10 weeks. CONCLUSIONS: Downregulation of Ass1 is evident in 3 different models of fibrosis with different aetiologies. Replicating loss of ASS1 in vitro in human RPTECs induced a pro-fibrotic, dedifferentiated phenotype which is independent of TGF-β signalling but dependent on proinflammatory and hypoxic stimuli. A small under-powered cohort of tubular specific Ass1 knock-out mice did not exhibit fibrosis within the kidney in the basal state in a short time-frame. However, using a larger cohort and challenging the tubular Ass1 knock out mouse with an injury such as ischaemia reperfusion may result in an exacerbation of fibrosis. Overall, loss of ASS1 may provide a novel link between initial inflammatory/ hypoxic insult in tubular cells and pro-fibrotic signalling driving renal disease which needs further interrogation in vivo.

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Finnie, Sarah Louise
Advisors dc:contributor.advisor
  • Denby, Laura
  • Morton, Nicholas

Subjects

dc:subject × 8

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Finnie, Sarah Louise. Ass1 and its role in renal fibrosis. The University of Edinburgh, 2020. https://hdl.handle.net/1842/36957